Kappa Bioscience

What Kappa Bioscience does

Kappa Bioscience is a Norway-based specialty ingredients company founded in 2006 and headquartered in Oslo. The company develops and sells high-purity vitamin K2 in the menaquinone-7 (MK-7) form, serving the nutraceutical, dietary supplement, and functional food manufacturing markets. Its core product offering is technically differentiated MK-7, a bioactive form of vitamin K2 that requires specialized fermentation and purification capabilities to produce at the purity grades demanded by premium supplement formulators.

The company operates a B2B ingredients model, supplying its MK-7 to manufacturers and formulators rather than selling directly to end consumers. Distribution is managed through a global network overseen by a dedicated Director Global Distributors Management, with the company having established a US-based President role to drive North American commercial expansion. The business is backed by venture capital, with Kistefos Venture Capital having led a 2009 funding round alongside SPRINGfondet, providing early growth capital.

Operationally, Kappa Bioscience runs with 51-100 employees and has pursued inorganic growth, acquiring ppm.Ingredients in January 2017 for an undisclosed amount to extend its specialty ingredients footprint. The leadership team combines founder-led R&D depth (founder Inger Reidun Aukrust serves as VP R&D and Chemistry) with commercial and operational hires including a CEO, US President, and VP Finance and Operations. The company remains private, and detailed financials, customer mix, and pricing structure are not disclosed in the available sources.

Name

Kappa Bioscience

Website

https://kappabio.com

Company type

Private

Founded year

2006

Headcount range

51–100 employees

Short description

Kappa Bioscience is a Norway-based specialty ingredients company founded in 2006 that develops and sells high-purity vitamin K2 (MK-7) to nutraceutical, dietary supplement, and functional food manufacturers worldwide.

Ownership category

akta.pro rank

Headquarters

HQ city

Oslo

HQ country

Norway

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Core offering

Kappa Bioscience develops and sells high-purity vitamin K2 in the form of menaquinone-7 (MK-7) as a specialty ingredient. The product, marketed as KappaMenaQ7, is supplied to nutraceutical and functional food manufacturers for use in dietary supplements and fortified foods targeting bone and cardiovascular health. The company also expanded its portfolio through the 2017 acquisition of ppm.Ingredients.

Differentiator

Problem solved

Functional benefit

Products and services

• KappaMenaQ7 (Vitamin K2 MK-7)

Ideal customer profiles1 record

Technology focussed No

API detail

API docs

API detail

Core technology

AI maturity

App detail

Recent moves4 records

Expansion highlights4 records

Broad incumbents

• BASF Nutrition & Health: BASF is a global leader in vitamin manufacturing, producing a broad portfolio of vitamins for human and animal nutrition. Competes with Kappa in the K2 space and across adjacent ingredient categories.
• dsm-firmenich: dsm-firmenich is one of the world's largest producers of vitamins and nutritional ingredients, including K2 offerings. As a multi-billion-dollar incumbent, it competes with Kappa on volume contracts and broader ingredient portfolios.
• ADM Nutrition: ADM is a global ingredient and nutrition company producing vitamins, flavors, and specialty ingredients for food, beverage, and supplement customers. A large incumbent competing for the same ingredient purchasing budgets.
• Lonza Capsules & Health Ingredients: Lonza manufactures vitamins and other nutraceutical ingredients at scale, serving dietary supplement and functional food brands. Overlaps with Kappa's ingredient supplier model and customer base.
• Balchem Corporation: Balchem is a publicly-traded specialty ingredient company with Human Nutrition, Animal Nutrition, and Plant Nutrition segments, including vitamins and nutrients. A much larger incumbent that competes with Kappa across overlapping ingredient categories.

Emerging players

• Glanbia Nutritionals: Glanbia supplies specialty nutritional ingredients and premixes to supplement and food brands, including vitamin offerings. Comparable to Kappa in serving B2B ingredient customers in the nutraceutical supply chain.
• Pharmachem (a Glanbia company): Pharmachem specializes in custom ingredient manufacturing and supply for the supplement industry, including vitamin and nutraceutical ingredients. Comparable B2B ingredient supplier model to Kappa.

Direct peers

• Gnosis by Lesaffre (K2VITAL): Gnosis produces K2VITAL branded vitamin K2 (MK-7 and MK-4) for supplement, food, and infant nutrition markets. Direct head-to-head competitor to Kappa in branded K2 ingredients.
• Nattopharma (now part of KD Pharma): Nattopharma was a pioneer in branded vitamin K2 (MK-7) ingredients and is the most directly comparable competitor to Kappa Bioscience, offering the same core molecule to nutraceutical and functional food customers globally.

Regional players

• Starlife (vitamin K2 specialist): Starlife is a vitamin K2 specialty player with primarily European/regional distribution. Comparable to Kappa as a focused K2 ingredient competitor, though with a more regional footprint.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/Kappabio
• LinkedInlinkedin.com/company/kappa-bioscience-as

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kappa Bioscience